Filing Details
- Accession Number:
- 0001209191-22-001688
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-05 16:25:51
- Reporting Period:
- 2022-01-01
- Accepted Time:
- 2022-01-05 16:25:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1236934 | J Paula Swain | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp, Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-01-01 | 8,678 | $0.00 | 72,371 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2022-01-04 | 9,319 | $73.21 | 81,690 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-01-04 | 9,319 | $73.46 | 72,371 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non Qualfied Stock Option (right to buy) | Disposition | 2022-01-04 | 9,319 | $0.00 | 9,319 | $73.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,870 | 2022-01-07 | No | 4 | M | Direct |
Footnotes
- Represents award of restricted stock units ("RSUs") that will vest 100% on December 31, 2025, subject to Paula Swain's continued service with the issuer through the applicable vesting dates. The RSUs may be settled only for shares of common stock on a one-for-one basis.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Represents weighted average sale price. Actual sale prices ranged from $73.31 - $73.73. Reporting person undertakes to provide upon requestby Securities and Exchange Commission, the issuer or a security holder of the issuer detailed information regarding the price and number ofshares sold within range indicated.
- Includes an aggregate of 33,663 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
- Beginning January 8, 2015, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Billionaire Hedge Funds
